Precision Pipeline Revenue and Competitors

Eau Claire, WI USA

Location

N/A

Total Funding

Energy/Oil

Industry

Estimated Revenue & Valuation

  • Precision Pipeline's estimated annual revenue is currently $346.1M per year.(i)
  • Precision Pipeline's estimated revenue per employee is $343,000

Employee Data

  • Precision Pipeline has 1009 Employees.(i)
  • Precision Pipeline grew their employee count by 9% last year.

Precision Pipeline's People

NameTitleEmail/Phone
1
VP, Health, Safety and EnvironmentReveal Email/Phone
2
VP, Estimating and Project ManagementReveal Email/Phone
3
VP OperationsReveal Email/Phone
4
VP Project ManagementReveal Email/Phone
5
ControllerReveal Email/Phone
6
VP FinanceReveal Email/Phone
7
Director EstimatingReveal Email/Phone
8
Director - Major ProjectsReveal Email/Phone
9
Director - Major ProjectsReveal Email/Phone
10
Director, Division InfrastructureReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.8M8563%N/AN/A
#2
$39.6M1476%N/AN/A
#3
$7.3M3719%N/AN/A
#4
$0.1M1-97%N/AN/A
#5
$7.3M3719%N/AN/A
#6
$57.1M2120%N/AN/A
#7
$443.5M1293-5%N/AN/A
#8
$5.9M30-12%N/AN/A
#9
$80M29741%N/AN/A
#10
$6.1M313%N/AN/A
Add Company

What Is Precision Pipeline?

As the first pipeline contractor designed to work within today's stringent pipeline-construction parameters, Precision Pipeline is the next generation pipeline contractor. Our focus on safety, environmental sensitivity, and cost effectiveness, allows us to provide a greater sense of confidence and care to our customers' most unique demands.\r\n\r\nPrecision Pipeline is a subsidiary of MasTec (MTZ).\r\n\r\nhttp://www.mastec.com/en/about/

keywords:N/A

N/A

Total Funding

1009

Number of Employees

$346.1M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Precision Pipeline News

2022-04-20 - Ashvattha Therapeutics Announces $69 Million in Series B ...

Ashvattha's hydroxyl dendrimer-based precision medicine pipeline includes clinical stage candidates for severe COVID-19, wet AMD/DME and ALS...

2022-04-20 - Praxis Precision Medicines Showcases Largest Targeted Epilepsy Portfolio in Industry at 2022 Epilepsy Day

A review of the significant progress in Praxis' early-stage epilepsy pipeline, including plans to declare antisense oligonucleotide (ASO)...

2022-04-19 - Flare Therapeutics Appoints Adrian Jubb as Chief Medical Officer

... for clinical excellence in advancing precision oncology pipeline ... to discover precision medicines for cancer and other diseases,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1090.9M4329N/AN/A
#2
$7634.2M240227%N/A